CLINICAL_TRIALS
research
· 2025-06-12
Clinical Trial Update: Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer [Phase 2]
Summary
This document provides an update on a Phase 2 clinical trial evaluating dose-escalated adaptive radiotherapy for thoracic disease in small cell lung cancer. Rec…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AHS Cancer Control Alberta | Conditions: Small Cell Lung Cancer | Phase 2 | Status: RECRUITING